바로가기 메뉴
본문 바로가기
해더 바로가기
페이지 하단 바로가기

About R&D

Our R&D capabilities are on par with global standards

Celltrion Pharm always looks
for ways to make better pharmaceutical products

Overview

R&D is the source of competitiveness for pharmaceutical companies. As such, Celltrion Pharm has committed its research capabilities in developing pharmaceutical products with global competitiveness. Celltrion Pharm Central Research Center holds outstanding competencies and expertise across all stages of pharmaceutical R&D including drug formulations research, analytical research, process development and manufacturing of various dosage forms.

Quality by Design

Celltrion Pharm applies QbD(Quality by Design) to all stages of development and manufacturing, QbD aims improving the quality of pharmaceutical products. To execute the QbD, We adopt statistical approach in research stage to clear understanding of the complicate parameters and materials those could influence the product quality, this approach will ensure that pharmaceutical products meet therapeutic and pharmaceutical equivalence leading to patient compliance.

Key Areas

Development of platform technologies for new drugs
Polymer based drug delivery system
Continuous manufacturing technology
Personalized medicine
Unmet medical needs
Improve administration and modified dosage forms
Change administration routes
Minimize tablet size, Fixed dose combination, improve stability and changing dosage form
New business models
Repositioning through AI & Big data
Open innovation
CDMO
First Follower strategy development
Patent strategies
Market preemption strategies
Strengthening the competitiveness of products